149715-45-7

Basic information

• Product Name: (S)-4-benzyl-2-hydroxymethylpiperazine
• Synonyms: (S)-4-benzyl-2-hydroxymethylpiperazine;(S)-4-benzyl-2-hydroxymethylpiperazine 2HCl;((2S)-4-Benzylpiperazin-2-yl)methanol
• CAS NO: 149715-45-7
• Molecular Formula: C₁₂H₁₈N₂O
• Molecular Weight: 206.28412
• Mol File: 149715-45-7.mol

Chemical Properties

• Boiling Point: 318.1 °C at 760 mmHg
• Flash Point: 146.2 °C
• Appearance: /
• Density: 1.083
• Vapor Pressure: 0.000154mmHg at 25°C
• Refractive Index: 1.551
• PKA: 14.97±0.10(Predicted)
• CAS DataBase Reference: (S)-4-benzyl-2-hydroxymethylpiperazine(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-4-benzyl-2-hydroxymethylpiperazine(149715-45-7)
• EPA Substance Registry System: (S)-4-benzyl-2-hydroxymethylpiperazine(149715-45-7)

Safety Data

• Hazardous Substances Data: 149715-45-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(S)-4-benzyl-2-hydroxymethylpiperazine is used as a precursor in the synthesis of various pharmaceutical compounds due to its unique structural features and chirality. Its potential as an antiviral, antipsychotic, or antihistaminic agent is being studied, highlighting its importance in drug development.
Used in Chemical Research:
In the field of chemical research, (S)-4-benzyl-2-hydroxymethylpiperazine serves as a model compound for understanding the effects of stereochemistry on biological activity. Its unique structure allows researchers to explore the relationship between molecular configuration and pharmacological efficacy.
Used in Drug Development:
(S)-4-benzyl-2-hydroxymethylpiperazine is utilized in drug development as a lead compound for the discovery of new therapeutic agents. Its potential applications in treating various conditions, such as viral infections, mental health disorders, and allergic reactions, make it a valuable asset in the search for novel medications.

InChI:InChI=1/C12H18N2O/c15-10-12-9-14(7-6-13-12)8-11-4-2-1-3-5-11/h1-5,12-13,15H,6-10H2/t12-/m0/s1

Upstream product

• 149648-95-3 (R)-3-(hydroxymethyl)-1-(phenylmethyl)-2,5-piperazinedione 
• 100-44-7 benzyl chloride 
• 76315-01-0 N-benzyl-N-(tert-butoxycarbonyl)glycine 
• 149648-94-2 N-<(1,1-dimethylethoxy)carbonyl>-N-(phenylmethyl)glycyl-D-serine methyl ester 
• 100-46-9 benzylamine 
• 366003-57-8 (+)-(2S)-methyl 2-(2-chloroacetylamino)-3-hydroxypropanoate 
• 149648-97-5 (S)-3-(hydroxymethyl)-1-(phenylmethyl)-2,5-piperazinedione 
• 1257855-72-3 (S)-tert-butyl 4-benzyl-2-(hydroxymethyl)piperazine-1-carboxylate 
• 1030377-21-9 (S)-2-(hydroxymethyl)piperazine-1-carboxylic acid tert-butyl ester 
• 100-52-7 benzaldehyde 

Downstream Products

• 956412-65-0 (S)-(-)-4-benzyl-2-(hydroxymethyl)piperazine-1-carbaldehyde 
• 317822-76-7 3-(tert-butyl-dimethyl-silanyloxymethyl)-1-(toluene-4-sulfonyl)-piperazine 
• 126766-61-8 (S)-methyl 3-(hydroxymethyl)-1-piperazinecarboxylate 
• 126766-62-9 (S)-methyl 4-<(3,4-dichlorophenyl)acetyl>-3-(hydroxymethyl)-1-piperazinecarboxylate 
• 126766-63-0 (S)-4-[2-(3,4-Dichloro-phenyl)-acetyl]-3-formyl-piperazine-1-carboxylic acid methyl ester 
• 126872-94-4 (S)-2-hydroxymethylpiperazine 
• 1030377-21-9 (S)-2-(hydroxymethyl)piperazine-1-carboxylic acid tert-butyl ester 
• 1257855-72-3 (S)-tert-butyl 4-benzyl-2-(hydroxymethyl)piperazine-1-carboxylate 
• 956412-67-2 (S)-(+)-1-benzyl-3-(methoxymethyl)piperazine 
• 956412-66-1 (S)-(-)-4-benzyl-2-(methoxymethyl)piperazine-1-carbaldehyde 

Relevant articles and documents

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula (I), or a stereoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.

Carbostyril carboxylic compounds and intermediates, preparation method and application thereof

The invention discloses carbostyril carboxylic compounds and hydrochlorides thereof and also discloses a preparation method of the compounds and the hydrochlorides thereof as well as an application of the compounds and the hydrochlorides thereof in preparing gram-positive bacterium-preventing or gram-negative bacterium-preventing drugs. Moreover, the invention discloses intermediates for preparing the compounds and a preparation method of the intermediates.

Enantiomerically pure 2-piperazinemethanols as novel chiral ligands of oxazaborolidine catalysts in enantioselective borane reductions

Novel enantiomerically pure 2-piperazinemethanols (3-5) were synthesized from 2-piperazinecarboxylic acid 1. The asymmetric reduction of aromatic ketones, ketimine and oxime ether has been performed with reagents prepared from 2-piprazinemethanol and borane to yield enantiomerically enriched alcohols and amines, respectively. The preferred absolute configuration of the product was dependent on the structure of the sulfonyl substituent in the chiral ligand.

A potent new class of κ-receptor agonist: 4-Substituted 1-(arylacetyl)- 2-[(dialkylamino)methyl]piperazines

The synthesis of 4-substituted 1-(arylacetyl)-2- [(alkylamino)methyl]piperazines (10-22, 26, 27, and 30-33) and their activities as κ-opioid receptor agonists are described. This includes a range of 4-acyl and 4-carboalkoxy derivatives with the latter ser